• / Free eNewsletters & Magazine
  • / My Account
Home>European Commission

European Commission

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  1. CTI BioPharma Expands Access To PIXUVRI® With Approval In Israel And Add-on Reimbursement Status In The Netherlands

    CTI BioPharma Expands Access To PIXUVRI® With Approval In Israel And Add-on Reimbursement Status In The Netherlands

  2. Part I. Not for release, publication or distribution, in whole or in part, directly or indirectly, in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws ...

    Part I. Not for release, publication or distribution, in whole or in part, directly or indirectly, in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.

  3. Germany's Schäuble Opposes Deficit Leeway for France

    Germany's Schäuble Opposes Deficit Leeway for France

  4. EU to Expand Sanctions to Some Russian, Ukrainian Companies -- 2nd Update

    EU to Expand Sanctions to Some Russian, Ukrainian Companies -- 2nd Update

  5. European Leaders Expected to Expand Sanctions Against Russia -- Update

    European Leaders Expected to Expand Sanctions Against Russia -- Update

  6. EU Clears Vodafone Purchase of ONO

    EU Clears Vodafone Purchase of ONO

  7. UPDATE: European stocks advance, euro falls after ECB meeting

    UPDATE: European stocks advance, euro falls after ECB meeting

  8. CEE Morning Briefing: Hungarian Bill on FX Loan Aid in Focus

    CEE Morning Briefing: Hungarian Bill on FX Loan Aid in Focus

  9. EU Approves Glaxo's Mekinist as Melanoma Treatment

    EU Approves Glaxo's Mekinist as Melanoma Treatment

  10. Anglo American to Sell Lafarge Tarmac Stake

    Anglo American to Sell Lafarge Tarmac Stake

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.